Get started
Author

Selene Rota

Observed name: S. Rota
ORCID: 0009-0008-7892-6635
Observed ORCID: 0009-0008-7892-6635
OpenAlex ID: A5011161152
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
2014 · E. Bajetta, I. Floriani, et al. · Annals of Oncology · 91
PDF
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer
2018 · Patrick G. Morris, Selene Rota, et al. · Clinical Breast Cancer · 61
Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature
2017 · Agnese Losurdo, Selene Rota, et al. · Critical Reviews in Oncology/Hematology · 46
Attitudes on fertility issues in breast cancer patients: an Italian survey
2015 · Nicoletta Biglia, Rosalba Torrisi, et al. · Gynecological Endocrinology · 39
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial
2021 · Gerardo Rosati, Sara Lonardi, et al. · European Journal of Cancer · 16
Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: A single institution experience
2013 · R. Torrisi, C.A. Garcia-Etienne, et al. · The Breast · 12
The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic
2021 · Maria Silvia Cona, Eliana Rulli, et al. · Supportive Care in Cancer · 9
PDF
A proposal of a “ready to use” COVID-19 control strategy in an Oncology ward: Utopia or reality?
2020 · Davide Dalu, Selene Rota, et al. · Critical Reviews in Oncology/Hematology · 9
Aromatase inhibitors in premenopause: Great expectations fulfilled?
2016 · Rosalba Torrisi, Selene Rota, et al. · Critical Reviews in Oncology/Hematology · 8
Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: a real-life study
2021 · Davide Dalu, Cinzia Fasola, et al. · Journal of Chemotherapy · 7
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients
2021 · Sara Demurtas, Nicla La Verde, et al. · The Pharmacogenomics Journal · 3
Weekly non-pegylated liposomal doxorubicin chemotherapy in heavily pre-treated patients with metastatic breast cancer.
2013 · Giovanna Masci, Chiara Gandini, et al. · PubMed · 3
COVID-19 and cancer: How outpatients (pts) and their caregivers (CGs) face to the pandemic—A survey from the midst of the Italian outbreak.
2021 · Maria Silvia Cona, Davide Dalu, et al. · Journal of Clinical Oncology · 1
1570P The emotional impact of COVID-19 outbreak on cancer out-patients and their caregivers: Impressions from the heart of the Italian pandemic
2020 · M.S. Cona, D. Dalu, et al. · Annals of Oncology · 1
PDF
The Effects of a Modified Mediterranean Diet on Gut Microbiota and Chemotherapy Side Effects in Patients With Metastatic Colorectal Cancer Undergoing First-Line Chemotherapy With or Without Either Antiepidermal Growth Factor Receptor or Antivascular Endothelial Growth Factor Agent: Protocol for a Randomized Pilot Study in Italy
2025 · Salvatore Artale, Francesca Filiali, et al. · JMIR Research Protocols
Fight against cancer in Italy: What patients, caregivers and healthy citizens think about care delivery from National Health System
2022 · Maria Silvia Cona, Anna Maria Mancuso, et al. · European Journal of Cancer Care
1712P Safety and efficacy of influenza and pneumococcal vaccines in cancer patients on active therapy: A prospective study
2021 · N.M. La Verde, D. Dalu, et al. · Annals of Oncology
The emotional impact of COVID-19 outbreak on cancer out-patients and their caregivers: Impressions from the heart of the Italian pandemic
2020 · Maria Silvia Cona, Davide Dalu, et al. · Annals of Oncology
HER2 assessment and Ki-67 labeling index in a cohort of male breast cases: The Ich Network on Cancer Research (INCaRe) experience.
2012 · Giovanna Masci, Michele Caruso, et al. · Journal of Clinical Oncology
A randomised phase II study of cetuximab plus gemcitabine/cisplatin combination in advanced pancreatic cancer (APC)
2007 · Stefano Cascinu, Rossana Berardi, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Works count: 20
Citation count: 306
H-index: 8
I10-index: 6
Year
Topic
Type